Brought to you by:
Zenith iliac branch graft ‘durable and highly effective’ in PRESERVE II study
Five-year outcomes from the PRESERVE II study support the safety and effectiveness of the investigational Zenith iliac branch graft (ZBIS, Cook Medical) in combination with the iCast covered stent (Getinge) to preserve internal iliac artery perfusion during endovascular aneurysm repair…
Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Getinge and Cook Medical today announced an exclusive sales and distribution agreement for the iCast covered stent system, which recently received Food and Drug Administration (FDA) premarket approval for the treatment of symptomatic iliac arterial occlusive disease. Cook Medical will…
Off-the-shelf branched endograft for TAAAs demonstrates safety and effectiveness through two years in both stable, symptomatic patients
Two-year target vessel-related freedom from all-cause and aneurysm-related mortality for an off-the-shelf multibranched endovascular device for the treatment of thoracoabdominal aortic aneurysms (TAAAs) came in at 78.5% and 98.6%, 2022 Vascular Annual Meeting (VAM) attendees heard. The data relate to…
Cloud-based fusion imaging found to improve operative metrics during FEVAR
A single-center retrospective review demonstrated a trend towards shorter operative times, and significant reductions in both iodinated contrast use and radiation exposure during fenestrated endovascular aneurysm repair (FEVAR) using Cydar’s EV Intelligent Maps—representing the first report of an improvement in…
Cook Medical receives FDA Breakthrough Device designation for Zenith Thoraco+ endovascular system
Cook Medical’s Zenith Thoraco+ endovascular system (Thoraco+) has received Breakthrough Device designation from the Food and Drug Administration (FDA), a press release reports. The company details that, while the product is not commercially available yet, the benefits of the designation…
Five-year STABLE II results show Zenith system makes the cut for acute complicated TBAD treatment
Joseph V. Lombardi, MD, reported long-term outcomes favoring the continued safety and effectiveness of a composite device (proximal covered stent graft plus distal bare stent) deployed for the endovascular repair of acute, type B aortic dissection (TBAD) complicated by aortic…
STABLE II results published on endovascular treatment of acute complicated TBAD with Cook Zenith
Thirty-day and one-year data from the STABLE II study have been published in the April 2020 issue of the Journal of Vascular Surgery (JVS) by Joseph V. Lombardi, MD, professor and chief of vascular surgery at Cooper University Hospital, Camden, New Jersey, and…